Bio-Bridge Science (OTCBB: BGES) Presentation at the China Growth Conference Available via Webcast
17 November 2005 - 2:52AM
Business Wire
Bio-Bridge Science, an Oak Brook Illinois-based biotech company,
announced today that its presentation at the China Growth
Conference in New York City is now available via webcast.
Bio-Bridge Science is one of 12 Chinese growth companies that
appeared at the China Growth Conference hosted by Adam Friedman
Associates. Investors wishing to access the presentation should
visit the Adam Friedman Associates website at www.adam-friedman.com
and click on the China Growth Conference webcast button. About the
Company: Bio-Bridge Science is a biotechnology firm focused on the
development of vaccines with broad therapeutic and preventive
applications. Through its wholly owned subsidiary in Beijing,
Bio-Bridge is developing a promising new HIV Vaccine, that is
expected to enter clinical trials early next year in China. The
vaccine, based on exclusive technology co-developed by CEO Liang
Qiao, an associate professor at Loyola University Chicago's Strich
School of Medicine, targets infection in mucosal tissues, the first
type of tissue attacked by HIV. The Chinese government, mindful of
the rapid expansion of AIDS in China has, through the "Green Mile
Policy" acted to expedite the approval of domestically produced HIV
Vaccines and has dramatically increased its spending on
AIDS-related research. In accordance with this policy, Bio-Bridge
expects to bring its therapeutic HIV Vaccine to market as early as
2008, far in advance of many other HIV Vaccines currently in
development. Bio-Bridge is currently constructing a new $3 million
state-of-the-art GMP research and manufacturing facility in
Beijing, which is expected to be completed by the end of this year.
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jun 2024 to Jul 2024
Bio Bridge Science (CE) (USOTC:BGES)
Historical Stock Chart
From Jul 2023 to Jul 2024
Real-Time news about Bio Bridge Science Inc (CE) (OTCMarkets): 0 recent articles
More Bio-Bridge Science News Articles